Abstract
OBJECTIVE
Expression levels of MUC1 and TLR-2 were evaluated in burning mouth syndrome (BMS) patients and compared with those of controls and oral lichen planus (OLP) patients. The relationships between the expression levels of MUC1 and TLR-2 and levels of salivary pro-inflammatory cytokines were also investigated.
DESIGN
Ten female BMS and ten female OLP patients were included. Ten female age-matched volunteers served as controls. RNA was isolated from stimulated whole saliva samples. Real-time PCR was used to quantify MUC1 and TLR-2 mRNA levels relative to β-actin and GAPDH mRNA levels. The clarified supernatants of saliva samples were used to measure IL-1β, IL-6, IL-8, and TNF-α levels. The level of blood contamination in saliva samples was also determined.
RESULTS
There were significant increases in MUC1 transcripts in BMS patients compared with OLP patients (1.766-fold) as well as controls (1.840-fold). There was no significant difference in TLR-2 expression among the groups. The OLP patients showed significantly higher levels of IL-6 and blood contamination in saliva than other groups. The levels of MUC1 or TLR-2 expression did not correlate significantly with the levels of cytokines or blood contamination in saliva.
CONCLUSIONS
MUC1 may play a role in the development and/or progression of BMS.
TY - JOUR
T1 - MUC1 and Toll-like receptor-2 expression in burning mouth syndrome and oral lichen planus.
AU - Kho,Hong-Seop,
AU - Chang,Ji-Youn,
AU - Kim,Yoon-Young,
AU - Kim,Yongdae,
Y1 - 2013/02/11/
PY - 2012/11/01/received
PY - 2012/12/29/revised
PY - 2013/01/15/accepted
PY - 2013/2/16/entrez
PY - 2013/2/16/pubmed
PY - 2014/1/31/medline
SP - 837
EP - 42
JF - Archives of oral biology
JO - Arch Oral Biol
VL - 58
IS - 7
N2 - OBJECTIVE: Expression levels of MUC1 and TLR-2 were evaluated in burning mouth syndrome (BMS) patients and compared with those of controls and oral lichen planus (OLP) patients. The relationships between the expression levels of MUC1 and TLR-2 and levels of salivary pro-inflammatory cytokines were also investigated. DESIGN: Ten female BMS and ten female OLP patients were included. Ten female age-matched volunteers served as controls. RNA was isolated from stimulated whole saliva samples. Real-time PCR was used to quantify MUC1 and TLR-2 mRNA levels relative to β-actin and GAPDH mRNA levels. The clarified supernatants of saliva samples were used to measure IL-1β, IL-6, IL-8, and TNF-α levels. The level of blood contamination in saliva samples was also determined. RESULTS: There were significant increases in MUC1 transcripts in BMS patients compared with OLP patients (1.766-fold) as well as controls (1.840-fold). There was no significant difference in TLR-2 expression among the groups. The OLP patients showed significantly higher levels of IL-6 and blood contamination in saliva than other groups. The levels of MUC1 or TLR-2 expression did not correlate significantly with the levels of cytokines or blood contamination in saliva. CONCLUSIONS: MUC1 may play a role in the development and/or progression of BMS.
SN - 1879-1506
UR - https://www.unboundmedicine.com/medline/citation/23411403/MUC1_and_Toll_like_receptor_2_expression_in_burning_mouth_syndrome_and_oral_lichen_planus_
L2 - https://linkinghub.elsevier.com/retrieve/pii/S0003-9969(13)00013-7
DB - PRIME
DP - Unbound Medicine
ER -